We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GAIN:NASDAQGladstone Investment Corporation - Business Development Company Analysis

Data as of 2026-06-11 - not real-time

$15.45

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Gladstone Investment Corp (GAIN) is trading at $15.45, comfortably above its 20‑day ($15.87) and 50‑day ($15.85) SMAs but still below the 200‑day SMA ($14.40) trend line, indicating a short‑term bullish bias within a longer‑term uptrend. The MACD has turned bearish (negative histogram) and volume is on a decreasing trend, suggesting caution despite the bullish price action. RSI sits at 44, well under overbought levels, leaving room for further upside. Valuation is strikingly cheap: a trailing P/E of 3.2 versus an industry average of 16.5, and a price‑to‑book of 0.92 against a book value of $16.78 per share. The dividend yield is robust at 6.24% with a modest payout ratio of 20%, pointing to dividend sustainability. However, the balance sheet is highly leveraged (debt‑to‑equity 84) and operating cash flow is negative, which tempers the appeal. Recent Q4 earnings call notes “strong portfolio growth,” providing a qualitative boost to the outlook. With a beta of 0.49 and 30‑day volatility of 34%, the stock shows low market‑wide sensitivity but high price swings, and the analyst consensus projects a modest upside of ~8% toward a target around $16.5‑$16.7.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • High dividend yield supports price stability
  • Bearish MACD and falling volume signal short‑term caution
  • Current price sits just above key support level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued valuation metrics (P/E 3.2 vs industry 16.5)
  • Target upside of ~8% toward consensus price of $16.5‑$16.7
  • Strong portfolio growth highlighted in Q4 earnings call

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend payout ratio with 6.24% yield
  • Low beta indicates defensive profile in market downturns
  • Long‑term BDC model provides steady cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth-8.60%
Profit Margin186.47%
P/E Ratio3.2
ROE31.66%
ROA2.00%
Debt/Equity84.47
P/B Ratio0.9
Op. Cash Flow$-101608000
Free Cash Flow$39.5M
Industry P/E16.5

Technical Analysis

TrendBullish
RSI43.8
Support$15.03
Resistance$17.00
MA 20$15.87
MA 50$15.85
MA 200$14.40
MACDBearish
VolumeDecreasing
Fear & Greed Index82.48

Valuation

Target Price$16.67
Upside/Downside7.88%
GradeUndervalued
TypeValue
Dividend Yield6.24%

Risk Assessment

Beta0.49
Volatility34.40%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.